Chemours Company Faces Securities Class Action Over Opteon Demand Claims
Oct 29, 2026
Chemours Company faces a securities class action lawsuit alleging misleading statements regarding Opteon aftermarket demand by executives. Eligible investors purchasing shares during the specified period may seek compensation.
Show all 48 updates